Assenagon Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $184M | Buy |
1,776,295
+899,942
| +103% | +$80.3M | 0.23% | 78 |
|
|
2026
Q1 | $62.9M | Sell |
876,353
-2,079,660
| -70% | -$160M | 0.1% | 161 |
|
|
2025
Q4 | $235M | Buy |
2,956,013
+370,926
| +14% | +$29.2M | 0.32% | 53 |
|
|
2025
Q3 | $195M | Buy |
2,585,087
+861,140
| +50% | +$59M | 0.27% | 73 |
|
|
2025
Q2 | $119M | Sell |
1,723,947
-1,799,877
| -51% | -$118M | 0.18% | 116 |
|
|
2025
Q1 | $239M | Buy |
3,523,824
+2,666,029
| +311% | +$160M | 0.4% | 46 |
|
|
2024
Q4 | $38.5M | Sell |
857,795
-1,134,375
| -57% | -$63.6M | 0.06% | 249 |
|
|
2024
Q3 | $125M | Buy |
1,992,170
+659,928
| +50% | +$38.5M | 0.23% | 77 |
|
|
2024
Q2 | $78.7M | Buy |
1,332,242
+1,077,027
| +422% | +$67.4M | 0.18% | 97 |
|
|
2024
Q1 | $20.4M | Sell |
255,215
-1,911,885
| -88% | -$146M | 0.05% | 277 |
|
|
2023
Q4 | $171M | Buy |
2,167,100
+1,049,871
| +94% | +$74.7M | 0.45% | 39 |
|
|
2023
Q3 | $78M | Sell |
1,117,229
-1,685,926
| -60% | -$119M | 0.24% | 69 |
|
|
2023
Q2 | $194M | Buy |
2,803,155
+569,291
| +25% | +$40.5M | 0.67% | 25 |
|
|
2023
Q1 | $166M | Buy |
2,233,864
+666,483
| +43% | +$55.9M | 0.59% | 35 |
|
|
2022
Q4 | $146M | Buy |
1,567,381
+712,595
| +83% | +$68.8M | 0.53% | 36 |
|
|
2022
Q3 | $81.5M | Buy |
854,786
+143,611
| +20% | +$14.2M | 0.31% | 72 |
|
|
2022
Q2 | $65.9M | Buy |
711,175
+681,051
| +2,261% | +$66.5M | 0.24% | 89 |
|
|
2022
Q1 | $3.05M | Buy |
30,124
+16,289
| +118% | +$1.71M | 0.01% | 681 |
|
|
2021
Q4 | $1.43M | Sell |
13,835
-166,365
| -92% | -$15.4M | ﹤0.01% | 943 |
|
|
2021
Q3 | $15.3M | Buy |
+180,200
| New | +$15.1M | 0.05% | 238 |
|
|
2021
Q2 | – | Sell |
-29,225
| Closed | -$2.2M | – | 1247 |
|
|
2021
Q1 | $2.2M | Sell |
29,225
-132,905
| -82% | -$9.68M | 0.01% | 691 |
|
|
2020
Q4 | $11.1M | Buy |
162,130
+46,239
| +40% | +$3.01M | 0.05% | 231 |
|
|
2020
Q3 | $6.77M | Buy |
115,891
+103,036
| +802% | +$6.41M | 0.04% | 266 |
|
|
2020
Q2 | $835K | Sell |
12,855
-237,469
| -95% | -$15M | 0.01% | 864 |
|
|
2020
Q1 | $14.9M | Buy |
250,324
+229,451
| +1,099% | +$15.3M | 0.12% | 130 |
|
|
2019
Q4 | $1.55M | Sell |
20,873
-322,896
| -94% | -$22.7M | 0.01% | 491 |
|
|
2019
Q3 | $21.7M | Buy |
343,769
+318,384
| +1,254% | +$18.9M | 0.15% | 108 |
|
|
2019
Q2 | $1.38M | Sell |
25,385
-1,176,097
| -98% | -$63.3M | 0.01% | 635 |
|
|
2019
Q1 | $64.8M | Buy |
1,201,482
+643,107
| +115% | +$39.7M | 0.61% | 37 |
|
|
2018
Q4 | $36.6M | Buy |
558,375
+546,385
| +4,557% | +$40.8M | 0.41% | 59 |
|
|
2018
Q3 | $944K | Sell |
11,990
-16,561
| -58% | -$1.18M | 0.01% | 650 |
|
|
2018
Q2 | $1.84M | Buy |
28,551
+7,231
| +34% | +$477K | 0.02% | 338 |
|
|
2018
Q1 | $1.33M | Sell |
21,320
-2,254
| -10% | -$162K | 0.02% | 365 |
|
|
2017
Q4 | $1.71M | Sell |
23,574
-695
| -3% | -$50.5K | 0.02% | 461 |
|
|
2017
Q3 | $1.97M | Buy |
24,269
+13,742
| +131% | +$1.09M | 0.02% | 332 |
|
|
2017
Q2 | $847K | Buy |
10,527
+273
| +3% | +$21.6K | 0.02% | 161 |
|
|
2017
Q1 | $805K | Sell |
10,254
-78,498
| -88% | -$6.27M | 0.02% | 181 |
|
|
2016
Q4 | $7M | Buy |
+88,752
| New | +$7.18M | 0.13% | 120 |
|
Other funds holding CVS
CF
HCM
Assenagon Asset Management's CVS Position: Q2 2026 in Review
Assenagon Asset Management increased its CVS Health (CVS) stake by 103% in Q2 2026, buying an estimated $80.3M and bringing the position to 1,776,295 shares worth $184M. The position accounts for 0.23% of the portfolio, ranked #78.
Assenagon Asset Management first reported a position in CVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $239M in Q1 2025. 844 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Assenagon Asset Management held 1,776,295 shares of CVS Health worth $184M as of Q2 2026.
- Assenagon Asset Management bought 899,942 CVS Health shares in Q2 2026, an estimated $80.3M.
- CVS Health made up 0.23% of Assenagon Asset Management's portfolio in Q2 2026, its #78 holding.
- Assenagon Asset Management first reported a position in CVS Health in Q4 2016 and has held it in 38 quarters since.
- Assenagon Asset Management's CVS Health position peaked at $239M in Q1 2025.
- 844 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.